Skip to main content

Featured

Trump Signals Near End to Iran Conflict Amid Conflicting Messages

  President Donald Trump has suggested that the United States is “very close” to winding down its military campaign in Iran, even as the conflict continues to escalate across the region. Speaking to reporters, Trump said the U.S. could end its operations within “two to three weeks,” emphasizing that Iran does not need to agree to a deal for the war to conclude. The remarks come as the administration prepares a national address on the Iran conflict, now entering its second month. The war has caused widespread destruction, disrupted global energy markets, and driven oil prices sharply upward. Despite Trump’s statements about de‑escalation, U.S. troop deployments have increased, with thousands of additional Marines sent to the Middle East.  Trump’s messaging has been inconsistent. While he has publicly hinted at a drawdown, he has also positioned U.S. forces for potential expanded operations and delayed major strikes in hopes of diplomatic progress—progress Iran denies is occu...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment